{"entity":{"type":"insider","cik":"0001300247","url":"/insider/0001300247","json_url":"/insider/0001300247.json","name":"Holtzman Steven H","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":13,"first":"2007-09-18","last":"2015-02-18","span_basis":"filed_date"},"name_variants":[{"name":"Holtzman Steven H","source":"filing","n_filings":13,"first_seen":"2007-09-18","last_seen":"2015-02-18"}],"transactions":[{"id":8053018,"accession":"0001127602-15-006771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-15-006771","line_url":"/filing/0001127602-15-006771#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Officer (EVP Corporate Development)","officer_title":"EVP Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2128.0,"shares_display":"2,128","price_per_share":389.11,"price_display":"389.11","price_state":"stated","total_value":828026.08,"total_display":"828,026.08","shares_owned_after":4321.0,"shares_owned_after_display":"4,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-18","scope":"insider"},{"id":6470212,"accession":"0001127602-14-034138","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-14-034138","line_url":"/filing/0001127602-14-034138#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Officer (EVP Corporate Development)","officer_title":"EVP Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1749.0,"shares_display":"1,749","price_per_share":335.65,"price_display":"335.65","price_state":"stated","total_value":587051.85,"total_display":"587,051.85","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-02","filed_date":"2014-12-03","scope":"insider"},{"id":7013422,"accession":"0001127602-14-032008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-14-032008","line_url":"/filing/0001127602-14-032008#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Officer (EVP Corporate Development)","officer_title":"EVP Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":330.0,"price_display":"330.00","price_state":"stated","total_value":577500.0,"total_display":"577,500.00","shares_owned_after":1749.0,"shares_owned_after_display":"1,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-11","filed_date":"2014-11-12","scope":"insider"},{"id":6574770,"accession":"0001127602-14-029119","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-14-029119","line_url":"/filing/0001127602-14-029119#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Officer (EVP Corporate Development)","officer_title":"EVP Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":330.97,"price_display":"330.97","price_state":"stated","total_value":579197.5,"total_display":"579,197.50","shares_owned_after":3499.0,"shares_owned_after_display":"3,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-02","scope":"insider"},{"id":6820820,"accession":"0001127602-14-018206","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-14-018206","line_url":"/filing/0001127602-14-018206#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Officer (EVP Corporate Development)","officer_title":"EVP Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1221.0,"shares_display":"1,221","price_per_share":289.15,"price_display":"289.15","price_state":"stated","total_value":353052.15,"total_display":"353,052.15","shares_owned_after":5749.0,"shares_owned_after_display":"5,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-19","filed_date":"2014-05-20","scope":"insider"},{"id":6188838,"accession":"0001127602-14-014900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-14-014900","line_url":"/filing/0001127602-14-014900#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Officer (EVP Corporate Development)","officer_title":"EVP Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1221.0,"shares_display":"1,221","price_per_share":291.0,"price_display":"291.00","price_state":"stated","total_value":355311.0,"total_display":"355,311.00","shares_owned_after":6970.0,"shares_owned_after_display":"6,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-17","filed_date":"2014-04-21","scope":"insider"},{"id":6468846,"accession":"0001127602-14-012093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-14-012093","line_url":"/filing/0001127602-14-012093#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Officer (EVP Corporate Development)","officer_title":"EVP Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1221.0,"shares_display":"1,221","price_per_share":334.83,"price_display":"334.83","price_state":"stated","total_value":408827.43,"total_display":"408,827.43","shares_owned_after":8191.0,"shares_owned_after_display":"8,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-17","filed_date":"2014-03-18","scope":"insider"},{"id":6468397,"accession":"0001127602-14-007120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-14-007120","line_url":"/filing/0001127602-14-007120#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Officer (EVP Corporate Development)","officer_title":"EVP Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1222.0,"shares_display":"1,222","price_per_share":327.9,"price_display":"327.90","price_state":"stated","total_value":400693.8,"total_display":"400,693.80","shares_owned_after":9412.0,"shares_owned_after_display":"9,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider"},{"id":5284200,"accession":"0001127602-13-027471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-13-027471","line_url":"/filing/0001127602-13-027471#line-1","is_derivative":false,"issuer_cik":"0000875045","issuer_name":"BIOGEN IDEC INC.","issuer_ticker":"BIIB","issuer_name_source":null,"issuer_url":"/issuer/0000875045","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Officer (EVP Corporate Development)","officer_title":"EVP Corporate Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3501.0,"shares_display":"3,501","price_per_share":238.98,"price_display":"238.98","price_state":"stated","total_value":836668.98,"total_display":"836,668.98","shares_owned_after":4885.0,"shares_owned_after_display":"4,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-17","filed_date":"2013-09-18","scope":"insider"},{"id":2246758,"accession":"0001181431-12-034422","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-034422","line_url":"/filing/0001181431-12-034422#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57573.0,"shares_display":"57,573","price_per_share":13.01,"price_display":"13.01","price_state":"stated","total_value":749024.73,"total_display":"749,024.73","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-31","filed_date":"2012-06-04","scope":"insider"},{"id":3303426,"accession":"0001181431-12-033720","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-12-033720","line_url":"/filing/0001181431-12-033720#line-3","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10958.0,"shares_display":"10,958","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":142454.0,"total_display":"142,454.00","shares_owned_after":57573.0,"shares_owned_after_display":"57,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-30","filed_date":"2012-05-31","scope":"insider"},{"id":3303422,"accession":"0001181431-12-033720","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-033720","line_url":"/filing/0001181431-12-033720#line-2","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":189303.0,"shares_display":"189,303","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":2460939.0,"total_display":"2,460,939.00","shares_owned_after":68531.0,"shares_owned_after_display":"68,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-29","filed_date":"2012-05-31","scope":"insider"},{"id":4118493,"accession":"0001181431-08-050739","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-08-050739","line_url":"/filing/0001181431-08-050739#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22103.0,"shares_display":"22,103","price_per_share":7.4,"price_display":"7.40","price_state":"stated","total_value":163562.2,"total_display":"163,562.20","shares_owned_after":256926.0,"shares_owned_after_display":"256,926","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-27","filed_date":"2008-08-29","scope":"insider"},{"id":8294285,"accession":"0001181431-07-057855","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-057855","line_url":"/filing/0001181431-07-057855#line-1","is_derivative":false,"issuer_cik":"0001113148","issuer_name":"INFINITY PHARMACEUTICALS, INC.","issuer_ticker":"INFI","issuer_name_source":null,"issuer_url":"/issuer/0001113148","owner_cik":"0001300247","owner_name":"Holtzman Steven H","owner_url":"/insider/0001300247","role":"Director, Officer (Chairman and CEO)","officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":9.1201,"price_display":"9.12","price_state":"stated","total_value":45600.5,"total_display":"45,600.50","shares_owned_after":234823.0,"shares_owned_after_display":"234,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875045","name":"BIOGEN IDEC INC.","url":"/issuer/0000875045","role":"Officer (EVP Corporate Development)","n_filings":9,"first_seen":"2013-09-18","last_seen":"2015-02-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001113148","name":"INFINITY PHARMACEUTICALS, INC.","url":"/issuer/0001113148","role":"Director, Officer (President and CEO)","n_filings":4,"first_seen":"2007-09-18","last_seen":"2012-06-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001300247","retrieved_at":"2026-08-21T06:46:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}